ClinicalTrials.gg
CompletedNCT05070182SERENADEUpdated Oct 7, 2021

Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)

An observational study in Brain Death, Brain Injuries and Brain Edema, sponsored by Aristotle University Of Thessaloniki. Completed at 1 site in Greece. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-10-07.

Sponsored by Aristotle University Of Thessaloniki · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
66
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The study will examine the resting energy need (REE) in patients suffering from brain damage. For the measurement of REE will be used a metabolic computer (which with continuous recording of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV) ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2, VCO2 and with the help of equations the values of REE and RQ.

Read the detailed description

This is a retrospective observational study concerning patients suffering from brain damage.

All the patients suffering from brain damage are monitored in order to examine their resting energy needs (REE). For the measurement of REE the metabolic computer (Medical Graphics, Ultima CCM, Minneapolis, USA) is used.

The main purpose of this study is to reveal the (REE) changing in patients with brain death semiology and examine if the REE changes could be related to the outcome of a patient with intracranial pathology. Moreover the study will examine if the changes in REE measurement are related to changes in flow velocities in the midbrain.

Any measurement shall be preceded by calibration of the metabolic computer pneumotachograph with a 3-liter syringe with an acceptable error of less than 9 ml / lit. The metabolic unit is calibrated for VO2 measurements with two calibration cylinders containing 21% and 12% O2 and for VCO2 measurements with calibration gases containing 5% and 0% CO2 respectively.

The measurement of flow velocities in the middle cerebral artery will be done with the transcranial Doppler using a low frequency (2 MHz) ultrasound head After their final diagnosis (brain death or not) the patients' characteristics will be compared according to the categorization as "brain dead" or not.

02

Conditions studied

  • Brain Death
  • Brain Injuries
  • Brain Edema
  • Brain Hemorrhage

Keywords

  • Resting energy expenditure (REE)
  • Brain Death
  • Brain injuries
03

In context

Brain Death

74 studies on the registry are indexed under Brain Death; 10 are open to participants now.

This study's enrollment of 66 is below the median of 80 across 33 observational studies indexed under Brain Death.

Browse Brain Death studies →

Lead sponsor

Aristotle University Of Thessaloniki is the lead sponsor of 282 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients, aged 18-90 years old, entering the ICU, having a GCS \<=8 before any intervention, having signs of intracranial damage after a traumatic brain injury or a cardiac arrest succesfull rescucitation or a brain hemorrhage due to aneurysm.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients entering the ICU
  • Age 18-90 years old
  • Clinical Diagnosis of brain damage
  • GCS \<=8

Exclusion criteria

Exclusion Criteria:

  • Patients \<18 years old and >90 years old,
  • Past history CNS disease (alzheimer's disease, multiple sclerosis, brain tumor, aneurysm) in the last 3 years
  • Past history of cachexia due to cancer
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
66 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with brain damage

    ICU patients with brain damage (due to cardiac arrest, intracranial hemorrhage or traumatic brain injury). and GCS upon entry \<=8. All patients will be examined with a transcranial doppler (TCD) and a metabolic computer (for the measurements of REE) After the final diagnosis the patients' characteristics will be compared according to if they were brain dead or not

    Diagnostic Test: REE - Resting Energy Expenditure · Diagnostic Test: Transcranial Doppler

Interventions

  • Diagnostic testREE - Resting Energy Expenditure

    REEs represent 60-70% of the needs for a sedentary person and 50% of physically active people. For the measurement of REE will be used the metabolic computer (Medical Graphics, Ultima CCM, Minneapolis, USA), which with continuous recording of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV) ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2, VCO2 and with the help of equations the values of REE and RQ. All patients in the study will be monitored with the metabolic computer. Their measurements will be recorded every day during their stay in the ICU.

  • Diagnostic testTranscranial Doppler

    The measurement of flow velocities in the middle cerebral artery will be done with the transcranial Doppler using a low frequency (2 MHz) ultrasound head. All patients entering the study will be examined with the TCD every day during their stay in the ICU.

06

What researchers measure

Primary outcomes

  1. REE changes

    Changes in REE in patients with brain damage

    Time frame: Day 0 (upon entry to ICU) up to 30 days

  2. MCA changes

    Changes in flow rates in Median Cerebral Artery (MCA) in patients with brain damage

    Time frame: Day 0 (upon entry to ICU) up to 30 days

  3. REE and MCA correlation

    Correlate the REE changes with those in flow rates in MCA

    Time frame: Day 0 (upon entry to ICU) up to 30 days

Secondary outcomes

  1. Prognostic value of REE

    Compare the values of REE upon entry in the ICU in patients with final diagnosis as brain dead or not

    Time frame: Day 0 (upon entry to ICU) up to 30 days

07

Study locations

1 site
  • Papageorgiou General Hospital
    Thessaloniki, Greece
08

References and documents

Publications

  • Babikian VL, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Bogdahn U, Caplan LR, Spencer MP, Tegeler C, Ringelstein EB, Alexandrov AV. Transcranial Doppler ultrasonography: year 2000 update. J Neuroimaging. 2000 Apr;10(2):101-15. doi: 10.1111/jon2000102101. PubMed 10800264 ↗
  • Marinoni M, Alari F, Mastronardi V, Peris A, Innocenti P. The relevance of early TCD monitoring in the intensive care units for the confirming of brain death diagnosis. Neurol Sci. 2011 Feb;32(1):73-7. doi: 10.1007/s10072-010-0407-1. Epub 2010 Sep 25. PubMed 20872036 ↗
  • Zijlstra N, ten Dam SM, Hulshof PJ, Ram C, Hiemstra G, de Roos NM. 24-hour indirect calorimetry in mechanically ventilated critically ill patients. Nutr Clin Pract. 2007 Apr;22(2):250-5. doi: 10.1177/0115426507022002250. PubMed 17374800 ↗
  • Bitzani M, Matamis D, Nalbandi V, Vakalos A, Karasakalides A, Riggos D. Resting energy expenditure in brain death. Intensive Care Med. 1999 Sep;25(9):970-6. doi: 10.1007/s001340050991. PubMed 10501754 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05070182
Collaborators
Papageorgiou General Hospital
Responsible party
Chrysoula Pourzitaki (Principal Investigator, Aristotle University Of Thessaloniki) — Principal investigator
First posted
Oct 7, 2021
Start date
Jun 1, 2018
Primary completion
Jun 30, 2020
Completion
Dec 30, 2020
Last update
Oct 7, 2021

Study contacts

Chryssa Pourzitaki, MD, PhD
principal investigator · Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion